CING Stock Analysis: Buy, Sell, or Hold?
CING - Cingulate Inc. Common Stock
$4.68
-0.23 (-4.68%)
▼
5d:
-11.7%
30d:
-4.29%
90d:
-18.75%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 18, 2026
Get Alerted When CING Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called CING this week
80% bullish • 1 bearish
80% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CING is down 11.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CING is down 11.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CING is currently trading at $4.68, which is considered slightly low relative to its 30-day fair value range of $4.67 to $5.27.
Technical Outlook: Technically, CING is in a downtrend. The price is currently testing key support at $4.67. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $23.00 (+391.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CING is in a downtrend. The price is currently testing key support at $4.67. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $23.00 (+391.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$4.67 -
$5.27
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.7%)
- BULLISH: Trading 391.5% below Wall St target ($23.00)
- WARNING: Recommendation downgraded due to -11.7% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$4.67 -
$5.27
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$0.58
(12.4%)
Support & Resistance Levels
Support Level
$4.67
Resistance Level
$6.05
Current Trend
Downtrend
Technical data as of
Jul 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.32
Wall Street Target
$23.00
(+391.5%)
Share & Embed Analysis
Last updated: July 13, 2026 10:33 PM ET
Data refreshes hourly during market hours. Next update: 11:33 PM
Data refreshes hourly during market hours. Next update: 11:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CING showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Jennifer L Callahan
BUY
4864 shares
2026-02-06
Matthew Brams
BUY
1946 shares
2026-02-06
Peter J Werth
BUY
19455 shares
2026-02-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$822 | 64 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 62 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 61 BUY |